Literature DB >> 7318347

Metoprolol and pindolol in hypertension: different effects on peripheral haemodynamics.

A Svensson, T Gudbrandsson, R Sivertsson, L Hansson.   

Abstract

1. Thirty-six patients with essential hypertension, were randomly allocated to double-blind treatment with either metoprolol (100--200 mg/day) or pindolol (5--10 mg/day). The effects upon blood pressure and peripheral blood flow were determined. Both drugs reduced blood pressure significantly. 2. Heart rate was significantly reduced by metoprolol but not by pindolol. 3. Vascular resistance at maximal dilatation was not changed by either pindolol. 4. At rest, pindolol reduced vascular resistance in the calf by 14% (P less than 0.05) but metoprolol tended to increase the resistance slightly. The difference in effect was also significant (P less than 0.005). 5. During leg muscle work there were no changes in vascular resistance in the forearm with either compound. 6. We conclude that pindolol appears to reduce blood pressure at least partly through vascular mechanisms, in contrast to metoprolol. The response to sympathetic stimulation induced by physical exercise does not differ between metoprolol- and pindolol-treated patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7318347     DOI: 10.1042/cs061425s

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  4 in total

Review 1.  ISA--vasodilatation: improvement of organ perfusion.

Authors:  L Hansson
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

2.  Effect of beta-adrenoceptor antagonists on prevalence of peripheral vascular symptoms in hypertensive patients.

Authors:  J A Steiner; R Cooper; K McPherson; A J Riley
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

Review 3.  Is the ISA of pindolol beta 2-adrenoceptor selective?

Authors:  W H Aellig; B J Clark
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

4.  Captopril and atenolol combined with hydrochlorothiazide in essential hypertension.

Authors:  L Andrén; B Karlberg; P Ohman; A Svensson; J Asplund; L Hansson
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.